Strategic Equity Capital plc · LSE:SEC

Strategic Equity Capital — Q1 2019 Earnings Presentation

35 slides from Strategic Equity Capital's earnings presentation, 2019

  1. Slide 1: Strategic Equity Capital plc Q1 Update 2019

    STRATEGIC EQUITY CAPITAL PLC Q1 Update 2019

  2. Slide 2: Risk considerations

    Risk considerations Risk Factors for Strategic Equity Capital plc (the Company”) – The general risk factors set out under the heading “D.1.Key Risks” of the Prospectus apply to the Company. In addition, potential investors should note the following factors: • There can be no guarantee that the inves

  3. Slide 3: Notice to recipients

    Notice to recipients This document is given to the recipient on condition that the recipient accepts that it is not a client of GVQ Investment Management Limited (“GVQIM”) and that hence, none of the client protections applicable to GVQIM’s clients are in fact in force or available, and GVQIM is not

  4. Slide 4: Contents

    Contents Q1 Update 2019 • Executive Summary 6 • Performance 7 • Detailed portfolio analysis 8 Outlook 16 Conclusion 22 Appendix 24 4

  5. Slide 5: Q1 Update 2019

    Q1 UPDATE 2019

  6. Slide 6: Executive summary

    Executive summary • SEC (the “Trust”) had a strong quarter; net assets per share increased by 8.6%¹, this was above the return of the FTSE Small Cap ex IT index (the “index”) which delivered a total return of 5.1%. SEC’s share price increased by 5.6% • Disappointing update from portfolio company Pro

  7. Slide 7: Fund performance

    Fund performance Annualised 20 15 14.2 11.6 10.0 10 8.6 7.9 7.1 5.9 5.1 4.9 5 1.9 0 -1.9 -3.1 -5 3 months 1 year 7 Feb 2017* 3 years 5 years 7 years SEC NAV Total Return FTSE Small Cap x IT Total Return Average 7.9% 7.2% 8.4% 9.5% 9.6% 9.6% Net Cash Good NAV return in the short and longer term. ‘All

  8. Slide 8: Q1 Attribution analysis

    Q1 Attribution analysis Positive attribution (top five) bps GVQIM Comment IFG Group 374 Full year results in-line. Cash offer from Epiris Private Equity at a 46% premium to the share price Strong full year results. Good progress in the new marketing strategy which has the potential to improve the 4i

  9. Slide 9: Changes to top 10 holdings

    Changes to top 10 holdings Top 10 Q4 2018 Top 10 Q1 2019 Company % of portfolio Company % of portfolio Equiniti Group 12.1 IFG Group 11.8 IFG Group 8.8 Equiniti Group 10.8 Tribal Group 8.2 Wilmington 7.2 4imprint Group 8.0 Tribal Group 6.7 Wilmington 7.1 4imprint Group 6.5 Proactis 5.9 Medica 6.3 Cl

  10. Slide 10: Top 10 holdings

    Top 10 holdings1 GVQIM GVQIM Net debt/ Company Sector Funds % of CF yield2 Investment thesis EBITDA NTM3 company NTM3 Structural growth; self-help in James Hay; M&A; IFG Group Financials c. 10% 9.7% -2.0x strategic review; new management team Growth through demonstrable cross-sell and margin Equinit

  11. Slide 11: IFG Group – a reminder of the thesis

    IFG Group – a reminder of the thesis IFG – a financial services company with two high quality discrete businesses • Structural growth from favourable long • Significant M&A in both the platform term trends including the need for and wealth management spaces. We individuals to manage their foresee on

  12. Slide 12: Approach for IFG Group

    Approach for IFG Group 2.00 Company announces proposed sale of Saunderson • On 25 March, a recommended cash offer was made by Epiris House and potential Elysian Fuels liability Funds at 193p, a 46% premium to the closing share price, a trailing 1.90 PE valuation of 21.4x. SEC owns 9.9% of the shares

  13. Slide 13: Proactis – company update

    Proactis – company update • Investment thesis – Proactis is global provider of cloud-based e-procurement and spend control software – Software is largely provided ‘as a service’ resulting in high (85%+) levels of recurring revenue. Historically, this has been matched with excellent customer retentio

  14. Slide 14: Highly concentrated and unconstrained portfolio

    Highly concentrated and unconstrained portfolio Sector exposure by value Value by market cap band 1 Healthcare 20.0% 1 2 1 <£50m 1.1% 8 9 8 7 1 2 7 Support services 17.3% 2 £50m - £100m 3.8% 6 3 Financials 17.3% 3 £100m - £200m 38.6% 4 Technology 16.7% 3 4 £200m - £300m 5.5% 6 5 5 Industrials 8.8% 5

  15. Slide 15: Portfolio valuation

    Portfolio valuation1 SEC SEC FTSE UK Small Cap ex weighted average median investment trusts Number of securities 17 17 156 Market cap (£m) 411 202 326 Consensus EV/EBITDA FY1 8.7x 9.3x 6.7x Consensus price earnings FY1 14.7x 15.7x 9.9x Consensus FY1 earnings growth 15.5% 13.4% 8.1% Consensus dividen

  16. Slide 16: Outlook

    OUTLOOK

  17. Slide 17: Bearishness around UK equities, marginal reversal in Q1

    Bearishness around UK equities, marginal reversal in Q1 Price and trailing DPS of UK MSCI index over time 240 200 160 120 80 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 Price Trailing DPS Highly negative view of UK equities reflected in >£11bn of net outflows

  18. Slide 18: Bear market checklist

    Bear market checklist Start of Proper Bear Markets Mar-00 Oct-07 Now Global Equity Valuations Trailing PE 33 17 17 Fwd PE 24 14 15 DY 1.3 2.1 2.5 CAPE 48 30 24 Global Equity Risk Premium 1.0% 3.3% 4.1% US Yield Curve (10Y minus 2Y) -0.5 0.0 0.1 Sentiment Global Analyst Bullishness (std dev) 1.7 1.0

  19. Slide 19: Market outlook and portfolio position

    Market outlook and portfolio position Market Outlook Portfolio Implications • Global economy is showing some signs of strain • Focus on companies with high degree of revenue visibility, – Weak macro-economic outlook in key European long term structural growth drivers, strong business models geograph

  20. Slide 20: Global private equity dry powder levels at record highs

    Global private equity dry powder levels at record highs Private Equity Dry Powder by Fund Type, 2009 - 2018 Worldwide M&A volumes in H1, 1998 - 2018 $1,200bn $2.5trn $1,000bn $2.0trn $800bn $600bn $1.5trn $400bn $1.0trn $200bn $0bn $0.5trn 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018¹ $0.0trn 1

  21. Slide 21: Earnings growth, cashflow and M&A to drive returns

    Earnings growth, cashflow and M&A to drive returns SEC portfolio • Double digit aggregate earnings • Private Equity ‘dry powder’ at record growth for the portfolio levels. Any resolution to UK uncertainty could see acquirers • Portfolio growth exceeds the market, return despite portfolio’s much lowe

  22. Slide 22: Conclusion

    CONCLUSION

  23. Slide 23: Conclusion

    Conclusion • SEC (the “Trust”) had a strong quarter with encouraging updates from the companies in the portfolio, demonstrating very good operational and strategic progress. This was allied, in the main, with positive share price performance and net assets per share increased by 8.6%¹ • SEC’s share

  24. Slide 24: Appendix

    APPENDIX

  25. Slide 25: Equiniti – a reminder of the thesis

    Equiniti – a reminder of the thesis Equiniti – a market leading specialist technology and business process outsourcer • Customers include 70% of FTSE 100 • High value on the strength of cash flows companies and 70% of newly listed and structural growth drivers to both PE companies and trade: • Oppor

  26. Slide 26: Portfolio investment themes

    Portfolio investment themes DIVERSIFIED DIGITAL HEALTH REGULATION AND PENSIONS INFRASTRUCTURE PHARMA COMPLIANCE AND AND SAVINGS BUILDING Demographic and Digital maturity agenda; Increasing compliance Increase in complexity US single family population changes replacement of legacy and regulatory burd

  27. Slide 27: International exposure of the portfolio

    International exposure of the portfolio End market sales Portfolio Companies 4 5 3 1 UK 61% Equiniti, IFG Group, Tribal, EMIS, Medica, Harworth 2 North America 24% 4imprint, Tyman, Clinigen 1 2 3 Europe 8% Clinigen, Ergomed, Wilmington 4 Asia 2% Alliance Pharma, Oxford Metrics, Tribal 5 RoW 5% Triba

  28. Slide 28: How we identify value in potential investments

    How we identify value in potential investments Main focus of most Main focus of most PUBLIC EQUITY INVESTORS PRIVATE EQUITY INVESTORS All investments undergo All investments are valued in-house, prospective using an in house cash-flow and historic leveraged buy-out model modelling Focus on recent re

  29. Slide 29: Asset quality

    There are strict criteria for inclusion in our funds Speculative Fair valued GARP1 Under valued Recovery Turnaround Distress growth A A Investment Asset quality Asset quality focus B Avoid Avoid B C Avoid C GVQIM’s research process aims to identify high quality coveted assets with attractive cash fl

  30. Slide 30: How we identify coveted assets

    How we identify coveted assets We look for characteristics which GVQIM believes potential acquirers value highly Qualitative Quantitative • Niche market leaders • High and/or improving ROCE • Orderly end markets, with some growth • Strong cash conversion • Sustainable business model/franchise/unique

  31. Slide 31: Our Black List screens out companies with fundamental business risks

    Our Black List screens out companies with fundamental business risks Operational • Excessive reliance on a single product, customer, supplier or distributor • The primary driver of profitability cannot be influenced by management (e.g. resources) • Inherently low margins • Structurally declining mar

  32. Slide 32: Research Committee ensures consistency of approach

    Research Committee ensures consistency of approach Preliminary Investment Final Investment Monitoring Idea generation Investment Memorandum Recommendation & review Recommendation Materials • Watch list • Company description • Company meeting • Counterparty analysis • Progress against • M&A transacti

  33. Slide 33: Long term track record

    Long term track record Cumulative rebased total returns1 300p CAGR¹ 280p SEC NAV 18.8% 260p 240p 220p 200p 180p 160p FTSE Small Cap ex IT 12.5% 140p 120p 100p 80p 60p 40p Jun 09 Jun 10 Jun 11 Jun 12 Jun 13 Jun 14 Jun 15 Jun 16 Jun 17 Jun 18 Strong cumulative performance since process improvements in

  34. Slide 34: Performance

    Performance Calendar Year annual performance YTD 2019 2018 2017 2016 2015 2014 2013 2012 Share Price Total Return 5.6% -17.6% 20.2% -9.0% 14.2% 32.7% 61.5% 25.6% NAV Total Return 8.6% -14.1% 21.7% 6.3% 12.1% 18.1% 46.1% 21.3% FTSE Small Cap ex Investment Trusts Total Return 5.1% -13.8% 15.6% 12.5% 1

  35. Slide 35: Contact details

    Contact details For further information regarding the SEC please contact the GVQ Investment Management marketing team below, or visit the Company’s website: www.strategicequitycapital.com For general enquiries, please contact: GVQ Investment Management Limited 16 Berkeley Street, London, W1J 8DZ Tel

Strategic Equity Capital — Q1 2019 Earnings Presentation on 6ix